Skip to main content
SpringerLink
Log in

Current concepts in Cryptococcosis

  • Current Topic: Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Cryptococcus neoformans has become an increasingly important pathogen. Cryptococcosis is an important cause of morbidity and mortality in immunocompromised hosts and is the second most common fungal infection complicating AIDS. In recent years, research has focused on the host defenses againstCryptococcus and has led to an improved understanding of the capsular virulence of the organism, the mechanisms of T-cell defenses, and the role of phagocytic cells in the fungistasis and killing of cryptococci. Amphotericin B with or without flucytosine has clearly improved treatment of cryptococcosis, but therapy is associated with significant toxicity. Current investigation is focused on the triazoles, which may offer improved therapy for cryptococcosis. In this report, we review recent developments in the understanding of the host defenses againstCryptococcocus and discuss current recommendations for the management of cryptococcosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rippon, J. W. Medical mycology. The pathogenic fungi and the pathogenic actinomycetes. Saunders, Philadelphia, 1988, p. 582–610.

    Google Scholar 

  2. Diamond, R. D. Cryptococcus neoformans. In: Mandell, G. L., Douglas, R. C., Bennett, J. E. (ed.): Principles and practice of infectious diseases. John Wiley, New York, 1985, p. 1460–1468.

    Google Scholar 

  3. Sabetta, J. R., Andriole, V. T. Cryptococcal infection of the central nervous system. Medical Clinics of North America 1985, 69: 333–344.

    PubMed  Google Scholar 

  4. Perfect, J. R., Durack, D. T., Gallis, H. A. Cryptococcemia. Medicine 1983, 62: 98–109.

    PubMed  Google Scholar 

  5. Kovacs, J. A., Kovacs, A. A., Wright, W. C., Gill, V. J., Tuazon, C. V., Gelmann, E. P., Lanc, H. C., Longfield, R., Parrillo, J. E., Bennett, J. E., Magur, H. Polis, M. Cryptococcosis in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1985, 103: 533–538.

    PubMed  Google Scholar 

  6. Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S., Rahal, J. J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 1986, 104: 234–240.

    PubMed  Google Scholar 

  7. Bhattacharjee, A. K., Bennett, J. E., Glaudemans, C. P. J. Capsular polysaccharides ofCryptococcus neoformans. Reviews of Infectious Diseases 1984, 6: 619–624.

    PubMed  Google Scholar 

  8. Granger, D. L., Perfect, J. R., Durack, D. T. Virulence ofCryptococcus neoformans. Regulation of capsule systhesis by carbon dioxide. Journal of Clinical Investigation 1985, 76: 508–516.

    PubMed  Google Scholar 

  9. Bulmer, G. S., Sams, M. D., Gunn, C. M. Cryptococcus neoformans. I. Non-encapsulated mutants. Journal of Bacteriology 1967, 94: 1475–1479.

    PubMed  Google Scholar 

  10. Kuzel, T. F., Cazin, J. Non-encapsulated variant ofCryptococcus neoformans. Infection and Immunity 1971, 3: 287–294.

    Google Scholar 

  11. Fromtling, R. A., Shadomy, H. J., Jacobson, E. S. Decreased virulence in stable, acapsular mutants ofCryptococcus neoformans. Mycopathologia 1982, 79: 23–29.

    PubMed  Google Scholar 

  12. Kwon-Chung, K. J., Polacheck, I., Bennett, J. E. Improved diagnostic medium for separation ofCryptococcus neoformans var.neoformans (serotypes A and D) andCryptococcus neoformans var.gattii (serotypes B and C). Journal of Clinical Microbiology 1982, 15: 535–537.

    PubMed  Google Scholar 

  13. Silkin, I. F., Hurd, N. J. New medium for differentiation ofCryptococcus neoformans serotype pairs. Journal of Clinical Microbiology 1982, 15: 169–171.

    PubMed  Google Scholar 

  14. Kwon-Chung, K. J., Bennett, J. E. Epidemiologic differences between two varieties ofCryptococcus neoformans. American Journal of Epidemiology 1984, 120: 123–130.

    PubMed  Google Scholar 

  15. Bennett, J. E., Kwon-Chung, K. J., Howard, D. H. Epidemiological differences among serotypes ofCryptococcus neoformans. American Journal of Epidemiology 1977, 105: 582–586.

    PubMed  Google Scholar 

  16. Ellis, D. H. Cryptococcus neoformans var.gatii in Australia. Journal of Clinical Microbiology 1987, 25: 430–431.

    PubMed  Google Scholar 

  17. Shadomy, H. J., Wood-Helie, S., Shadomy, S., Dismukes, W. E., Chau, R. Y., andthe National Institute of Allergy and Infectious Diseases Mycoses Study Group Biochemical serogrouping of clinical isolates ofCryptococcus neoformans. Diagnostic Microbiology and Infectious Disease 1987, 6: 131–138.

    PubMed  Google Scholar 

  18. Fromtling, R. A., Abruzzo, G. K., Bulmer, G. S. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC. Mycopathologia 1986, 94: 27–30.

    PubMed  Google Scholar 

  19. Shimizu, R. Y., Howard, D. H., Clancy, M. N. The variety ofCryptococcus neoformans in patients with AIDS. Journal of Infectious Diseases 1986, 154: 1042.

    PubMed  Google Scholar 

  20. Rinaldi, M. G., Drutz, D. J., Howell, A., Sande, M. A., Wofsy, C. B., Hadley, W. K. Serotypes ofCryptococcus neoformans in patients with AIDS. Journal of Infectious Diseases 1986, 153: 642.

    PubMed  Google Scholar 

  21. Bottone, E. J., Salkin, I. F., Hurd, N. J., Wormser, G. P. Serogroup distribution ofCryptococcus neoformans in patients with AIDS. Journal of Infectious Diseases 1987, 156: 242.

    PubMed  Google Scholar 

  22. Small, J. M., Mitchell, T. G., Wheat, R. W. Strain variation in composition and molecular size of the capsular polysaccharide ofCryptococcus neoformans serotype A. Infection and Immunity 1986, 54: 735–741.

    PubMed  Google Scholar 

  23. Bottone, E. J., Toam, M., Johansson, B. E., Wormser, G. P. Poorly encapsulatedCryptococcus neoformans from patients with AIDS. I. Preliminary observations. AIDS Research 1986, 2: 211–218.

    PubMed  Google Scholar 

  24. Bottone, E. J., Wormser, G. P. Poorly encapsulatedCryptococcus neoformans from patients with AIDS. II. Correlation of capsule size observed directly in cerebrospinal fluid with that after animal passage. AIDS Research 1986, 2: 219–235.

    PubMed  Google Scholar 

  25. Breen, J. F., Lee, I. C., Vogel, F. R., Friedman, H. Cryptococcal polysaccharide-induced modulation of murine immune responses. Infection and Immunity 1982, 36: 47–51.

    PubMed  Google Scholar 

  26. Miller, G. P. G. The immunologic of cryptococcal disease. Seminars in Respiratory Infectious 1986, 1: 45–52.

    Google Scholar 

  27. Diamond, R. D. Antibody-killing ofCryptococcus neoformans by human peripheral blood mononuclear cells. Nature 1974, 247: 148–150.

    PubMed  Google Scholar 

  28. Diamond, R. D., Allison, A. C. Nature of the effector cells responsible for antibody-dependent cell-mediated killing ofCryptococcus neoformans. Infection and Immunity 1976, 14: 716–720.

    PubMed  Google Scholar 

  29. Miller, G. P. G., Kohl, S. Antibody-dependent leukocyte killing ofCryptococcus neoformans. Journal of Immunology 1983, 131: 1455–1459.

    Google Scholar 

  30. Diamond, R. D., Bennett, J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Annals of Internal Medicine 1974, 80: 176–181.

    PubMed  Google Scholar 

  31. Henderson, D. K., Bennett, J. E., Huber, M. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. Journal of Clinical Investigation 1982, 69: 1185–1190.

    PubMed  Google Scholar 

  32. Henderson, D. K., Kan, V. L., Bennett, J. E. Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro. Clinical and Experimental Immunology 1986, 65: 639–646.

    PubMed  Google Scholar 

  33. Kozel, T. R., Gotschlich, E. C. The capsule ofCryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infection and Immunity 1977, 16: 99–106.

    PubMed  Google Scholar 

  34. Diamond, R. D., Root, R. K., Bennett, J. E. Factors influencing killing ofCryptococcus neoformans by human leukocytes in vitro. Journal of Infectious Diseases 1972, 125: 367–376.

    PubMed  Google Scholar 

  35. Davies, S. F., Clifford, D. R., Hoidal, J. R., Repine, J. E. Opsonic requirements for the uptake ofCryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. Journal of Infectious Diseases 1982, 145: 870–874.

    PubMed  Google Scholar 

  36. Kozel, T. R., Highson, B., Stratton, C. J. Localization on encapsulatedCryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infection and Immunity 1984, 43: 574–579.

    PubMed  Google Scholar 

  37. Griffin, F. M. Roles of macrophage FC and C3b receptors on phagocytosis of immunologically coatedCryptococcus neoformans. Proceedings of the National Academy of Sciences of the USA 1981, 78: 3853–3857.

    PubMed  Google Scholar 

  38. Macher, A. M., Bennett, J. E., Gadek, J. F., Frank, M. M. Complement depletion in cryptococcal sepsis. Journal of Immunology 1978, 120: 1686–1690.

    Google Scholar 

  39. Diamond, R. D., Bennett, J. E. Growth ofCryptococcus neoformans within human macrophages in vitro. Infection and Immunity 1973, 7: 231–236.

    PubMed  Google Scholar 

  40. Johnston, R. B., Godzik, C. A., Cohn, Z. A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. Journal of Experimental Medicine 1978, 148: 115–127.

    PubMed  Google Scholar 

  41. Ganz, T., Selsted, M. E., Szklarek, S. S., Harwig, S. L., Daher, K., Bainton, D. F., Lehrer, R. I. Defensins: natural peptide antibiotics of human neutrophils. Journal of Clinical Investigation 1985, 76: 1427–1435.

    PubMed  Google Scholar 

  42. Granger, D. L., Hibbs, J. B., Perfect, J. R., Durack, D. T. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. Journal of Clinical Investigation 1988, 81: 1129–1136.

    PubMed  Google Scholar 

  43. Elsbach, P., Weiss, J. A reevaluation of the roles of the O2-dependent and O2-independent microbiocidal systems of phagocytes. Reviews of Infectious Diseases 1983, 5: 843–853.

    PubMed  Google Scholar 

  44. Perfect, J. R., Granger, D. L., Durack, D. T. Effects of antifungal agents and gamma interferon on macrophages cytotoxicity for fungi and tumor cells. Journal of Infectious Diseases 1987, 156: 316–323.

    PubMed  Google Scholar 

  45. Rich, A. R. The pathogenesis of tuberculosis. C. C. Thomas, Springfield, IL, 1951, p. 606–611.

    Google Scholar 

  46. Hibbs, J. B., Taintor, R. R., Vavrin, Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochemical and Biophysical Research Communications 1984, 123: 716–723.

    PubMed  Google Scholar 

  47. Drapier, J. C., Hibbs, J. B. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: inhibition involves the iron-sulfur prosthetic group and is reversible. Journal of Clinical Investigation 1986, 78: 790–797.

    PubMed  Google Scholar 

  48. Stuehr, D. J., Marletta, M. A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response toEscherichia coli lipopoly-saccharide. Proceedings of the National Academy of Sciences of the USA 1985, 78: 7738–7742.

    Google Scholar 

  49. Green, L. C., Ruiz de Luzuriaga, K. R., Wagner, D. A., Rand, W., Istfan, N., Young, V. R., Tannenbaum, S. R. Nitrate biosynthesis in man. Proceedings of the National Academy of Sciences of the USA 1981, 78: 7764–7768.

    PubMed  Google Scholar 

  50. Wagner, D. A., Young, V. R., Tannenbaum, S. R. Mammalian nitrate biosynthesis: incorporation of15NH3 into nitrate is enhanced by endotoxin treatment. Proceedings of the National Academy of Sciences of the USA 1983, 80: 4518–4521.

    PubMed  Google Scholar 

  51. Diamond, R. D., Bennett, J. E. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response toCryptococcus neoformans. Journal of Infectious Diseases 1973, 127: 694–708.

    PubMed  Google Scholar 

  52. Schimpff, S. C., Bennett, J. E. Abnormalities in cell-mediated immunity in patients withCryptococcus neoformans infection. Journal of Allergy and Clinical Immunology 1975, 55: 430–441.

    PubMed  Google Scholar 

  53. Murphy, J. W., Moorhead, J. W. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. Journal of Immunology 1982, 128: 276–283.

    Google Scholar 

  54. Lipscomb, M. F., Alvarellos, T., Toews, G. B., Tompkins, R., Evans, Z., Koo, G., Kumar, V. Role of natural killer cells in resistance toCryptococcus neoformans in mice. American Journal of Pathology 1987, 128: 354–361.

    PubMed  Google Scholar 

  55. Graybill, J. R., Aherns, J. Immunization and complement interactions in host defenses against murine cryptococcosis. Journal of the Reticuloendothelial Society 1981, 30: 347–357.

    PubMed  Google Scholar 

  56. Perfect, J. R., Durack, D. T. Chemotactic activity of cerebrospinal fluid in experimental cryptococcal meningitis. Sabouraudia 1985, 23: 37–45.

    PubMed  Google Scholar 

  57. Perfect, J. R., Durack, D. T. Effects of cyclosporine in experimental cryptococcal meningitis. Infection and Immunity 1985, 50: 22–26.

    PubMed  Google Scholar 

  58. Perfect, J. R., Hobbs, M. M., Granger, D. L., Durack, D. T. Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infection and Immunity 1988, 56: 849–854.

    PubMed  Google Scholar 

  59. Eng, R. H. K., Bishburg, E., Smith, E. M., Kapila, R. Cryptococcal infections in patients with acquired immune deficiency syndrome. American Journal of Medicine 1986, 81: 19–23.

    Google Scholar 

  60. Butler, W. T., Alling, D. W., Spickard, A., Utz, J. P. Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. A follow-up study of forty patients. New England Journal of Medicine 1964, 270: 59–67.

    PubMed  Google Scholar 

  61. DeWytt, C. N., Dickson, P. L., Holt, G. W. Cryptococcal meningitis. A review of 32 years experience. Journal of Neurological Sciences 1982, 53: 283–292.

    Google Scholar 

  62. Sarosi, G. A., Parker, J. D., Doti, I. L., Tosh, F. E. Amphotericin B in cryptococcal meningitis. Long-term results of treatment. Annals of Internal Medicine 1969, 71: 1079–1087.

    PubMed  Google Scholar 

  63. Lewis, J. L., Rabinovich, S. The wide spectrum of cryptococcal infections. American Journal of Medicine 1972, 53: 315–322.

    PubMed  Google Scholar 

  64. Dismukes, W. E., Cloud, G., Gallis, H. A., Kerkering, T. M., Medoff, G., Craven, P. C., Kaplowitz, L. G., Fisher, J. F., Gregg, C. R., Bowles, C. A., Shadomy, S., Stamm, A. M., Biasio, R. G., Kaufman, L., Soong, S., Blackwelder, W. C., andthe National Institute of Allergy and Infectious Diseases Mycoses Study Group Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. New England Journal of Medicine 1987, 317: 334–341.

    PubMed  Google Scholar 

  65. Ricciardi, D. D., Sepkowitz, D. V., Berkowitz, L. B., Bienenstock, H., Maslow, M. Cryptococcal arthritis in a patient with acquired immune deficiency syndrome. Case report and review of the literature. Journal of Rheumatology 1986, 13: 455–458.

    PubMed  Google Scholar 

  66. Lewis, W., Lipsick, J., Cammarosano, C. Cryptococcal myocarditis in acquired immune deficiency syndrome. American Journal of Cardiology 1985, 55: 1240.

    PubMed  Google Scholar 

  67. LaFont, A., Wolff, M., Marche, C., Clair, B., Regnier, B. Overwhelming myocarditis due toCryptococcus neoformans in an AIDS patient. Lancet 1987, ii: 1145–1146.

    Google Scholar 

  68. Brivet, F., Livartowski, J., Herve, P., Rain, B., Dormont, J. Pericardial cryptococcal disease in acquired immune deficiency syndrome. American Journal of Medicine 1987, 82: 1273.

    Google Scholar 

  69. Wasser, L., Talavera, W. Pulmonary cryptococcosis in AIDS. Chest 1987, 92: 692–695.

    PubMed  Google Scholar 

  70. Newman, T. G., Soni, A., Acaron, S., Huang, C. T. Pleural cryptococosis in acquired immune deficiency syndrome. Chest 1987, 91: 459–461.

    PubMed  Google Scholar 

  71. Glick, M., Cohen, S. G., Cheney, R. T., Crooks, G. W., Greenberg, M. S. Oral manifestations of disseminatedCryptococcus neoformans in a patient with acquired immunodeficiency syndrome. Oral Surgery, Oral Medicine, Oral Pathology 1987, 64: 454–459.

    Google Scholar 

  72. Lief, M., Sarfarazi, F. Prostatic cryptococcosis in acquired immune deficiency syndrome. Urology 1986, 28: 318–319.

    PubMed  Google Scholar 

  73. Witt, D., McKay, D., Schwam, L., Goldstein, D., Gold, J. Acquired immune deficiency syndrome presenting as bone marrow and mediastinal cryptococcosis. American Journal of Medicine 1987, 82: 149–150.

    PubMed  Google Scholar 

  74. Torres, R. A. Cryptococcal mediastinitis mimicking lymphoma in the acquired immune deficiency syndrome. American Journal of Medicine 1987, 83: 1004–1005.

    PubMed  Google Scholar 

  75. Edson, R. S., Fernandez-Guerrero, M. L., Roberts, G. D., VanScoy, R. E. Clinical and laboratory features of cryptococcosis. A five-year experience. Minnesota Medicine 1987, 70: 337–342.

    PubMed  Google Scholar 

  76. Berger, M. P., Paz, J. Diagnosis of cryptococcal meningitis. Journal of the American Medical Association 1976, 236: 2517–2518.

    PubMed  Google Scholar 

  77. Gonyea, E. F. Cisternal panculture and cryptococcal meningitis. Archives of Neurology 1973, 28: 200–201.

    PubMed  Google Scholar 

  78. Bloomfield, N., Gordon, M. A., Elmendorf, D. F. Detection ofCryptococcus neoformans antigen in body fluids by latex particle agglutination. Proceedings of the Society for Experimental Biology and Medicine 1963, 114: 64–67.

    PubMed  Google Scholar 

  79. Prevost, E., Newell, R. Commercial cryptococcal latex kit. Clinical evaluation in a medical center hospital. Journal of Clinical Microbiology 1978, 8: 529–533.

    PubMed  Google Scholar 

  80. Hopwood, V., Warnock, D. W. New developments in the diagnosis of opportunistic fungal infection. European Journal of Clinical Microbiology 1986, 5: 379–388.

    PubMed  Google Scholar 

  81. Wu, T. C., Koo, S. Y. Comparison of three commercial latex kits for detection of cryptococcal antigen. Journal of Clinical Microbiology 1983, 18: 1127–1130.

    PubMed  Google Scholar 

  82. Bennett, J. E., Bailey, J. W. Control for rheumatoid factor in the latex test for cryptococcosis. American Journal of Clinical Pathology 1971, 56: 360–365.

    PubMed  Google Scholar 

  83. Gordon, M. A., Lapa, E. W. Elimination of rheumatoid factor in the latex test for cryptococcosis. American Journal of Clinical Pathology 1974, 61: 488–494.

    PubMed  Google Scholar 

  84. Stockman, L., Roberts, G. D. Corrected version. Specificity of the latex for cryptococcal antigen: a rapid, simple method for eliminating interference factors. Journal of Clinical Microbiology 1983, 17: 945–947.

    Google Scholar 

  85. McManus, E. J., Jones, M. J. Detection of aTrichosporon beigelii antigen cross-reactive withCryptococcus neoformans capsular polysaccharide in serum from a patient with disseminatedTrichosporon infection. Journal of Clinical Microbiology 1985, 21: 681–685.

    PubMed  Google Scholar 

  86. Zimmer, B. L., Roberts, G. D. Rapid selective urease test for presumptive identification ofCryptococcus neoformans. Journal of Clinical Microbiology 1979, 10: 380–381.

    PubMed  Google Scholar 

  87. Melo, J. C., Srinivasan, S., Scott, M. L., Raff, M. J. Cryptococcus albidus meningitis. Journal of Infection 1980, 2: 79–82.

    PubMed  Google Scholar 

  88. DaCunha, T., Lusins, J. Cryptococcus albidus meningitis. Southern Medical Journal 1973, 66: 1230–1243.

    PubMed  Google Scholar 

  89. Wieser, H. G. Zur Frage der Pathogenität derCryptococcus albidus. Schweizerische Medizinische Wochenschrift 1973, 103: 475–481.

    PubMed  Google Scholar 

  90. Gluck, J., Myers, J. P., Pass, L. M. Cryptococcemia due toCryptococcus albidus. Southern Medical Journal 1987, 80: 511–513.

    PubMed  Google Scholar 

  91. Lynch, J. P., Schaberg, D. R., Kissner, D. G., Kauffman, C. A. Cryptococcus laurentii lung abscess. American Review of Respiratory Disease 1981, 123: 135–138.

    PubMed  Google Scholar 

  92. Kamalam, A., Yesudian, P., Thambiah, A. S. Cutaneous infection byCryptococcus laurentii. British Journal of Dermatology 1977, 97: 221–223.

    PubMed  Google Scholar 

  93. Binder, L., Csillag, A., Toth, G. Diffuse infiltration of the lungs associated withCryptococcus luteolus. Lancet 1956, ii: 1043–1045.

    Google Scholar 

  94. Carton, C. A., Mount, L. A. Neurosurgical aspects of cryptococcosis. Journal of Neurosurgery 1951, 8: 143–156.

    PubMed  Google Scholar 

  95. Spickard, A., Butler, W. T., Andriole, V., Utz, J. P. The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Annals of Internal Medicine 1963, 58: 66–83.

    PubMed  Google Scholar 

  96. Utz, J. P., Shadomy, S., McGehee, R. F. Flucytosine. New England Journal of Medicine 1972, 286: 777–778.

    PubMed  Google Scholar 

  97. Kauffman, C. A., Frame, P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrobial Agents and Chemotherapy 1977, 11: 244–247.

    PubMed  Google Scholar 

  98. Utz, J. P., Garriques, I. L., Sande, M. A., Warner, J. F., Mandell, G. L., McGehee, R. F., Duma, R. J., Shadomy, S. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. Journal of Infectious Diseases 1975, 132: 368–373.

    PubMed  Google Scholar 

  99. Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H., Leonard, J., Fields, B. T., Bradshaw, M., Haywood, H., McGee, Z. A., Cate, T. R., Cobbs, C. G., Warner, J. F., Alling, D. W. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New England Journal of Medicine 1979, 301: 126–131.

    PubMed  Google Scholar 

  100. Stamm, A. M., Diasio, R. B., Dismukes, W. E. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. American Journal of Medicine 1987, 83: 236–242.

    PubMed  Google Scholar 

  101. Granier, F., Kanitakis, J., Hermier, C., Zhu, Y. Y., Thivolet, J. Localized cutaneous cryptococcosis sucessfully treated with ketoconazole. Journal of the American Academy of Dermatology 1987, 16: 243–249.

    PubMed  Google Scholar 

  102. Perfect, J. R., Durack, D. T., Hamilton, J. D., Gallis, H. A. Failure of ketoconazole in cryptococcal meningitis. Journal of the American Medical Association 1982, 247: 3349–3351.

    PubMed  Google Scholar 

  103. Perfect, J. R., Savani, D. V., Durack, D. T. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrobial Agents and Chemotherapy 1986, 29: 579–583.

    PubMed  Google Scholar 

  104. Arndt, C. A., Walsh, T. J., McCully, C. L., Balis, F. M., Pizzo, P. A., Poplack, D. G. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. Journal of Infectious Diseases 1988, 157: 178–179.

    PubMed  Google Scholar 

  105. DeFernandenz, E. P., Patino, M. M., Graybill, J. R., Tarbit, M. H. Treatment of cryptococcal meningitis in mice with fluconazole. Journal of Antimicrobial Chemotherapy 1986, 18: 261–270.

    PubMed  Google Scholar 

  106. Byrne, W. R., Wajszczuk, C. P. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. Annals of Internal Medicine 1988, 108: 384–385.

    PubMed  Google Scholar 

  107. DeGans, J., Schattenkerk, J. K. M. E., VanKetel, R. J. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome. British Medical Journal 1988, 296: 339.

    PubMed  Google Scholar 

  108. Viviani, M. A., Tortorano, A. M., Giani, P. C., Ariei, C., Goglio, S. A., Crocchiolo, P., Almavira, M. Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1987, 106: 166.

    Google Scholar 

  109. Bennett, J. E. Treatment of cryptococcal, candidal, and coccidioidal meningitis. In: Remington, J. S., Swartz, M. N. (ed.) Current clinical topics in infectious diseases. McGraw-Hill, New York, 1981, p. 54–88.

    Google Scholar 

  110. Polsky, B., Depman, M. R., Gold, J. W. M., Galicich, J. H., Armstrong, D. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. American Journal of Medicine 1986, 81: 24–28.

    PubMed  Google Scholar 

  111. Lyons, R. W., Andriole, V. T. Fungal infections of the CNS. Neurologic Clinics 1986, 4: 159–170.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, 333 Cedar Street, 06510, New Haven, Connecticut, USA

    T. F. Patterson & V. T. Andriole

Authors
  1. T. F. Patterson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. T. Andriole
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patterson, T.F., Andriole, V.T. Current concepts in Cryptococcosis. Eur. J. Clin. Microbiol. Infect. Dis. 8, 457–465 (1989). https://doi.org/10.1007/BF01964060

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964060

Keywords

Search

Navigation